Naturhouse HealthXMAD:NTH -1.18%81 Return-on-Tangible-Asset is 20.44% as of Dec. 2025, which is 28% below its 10-year median of 28.28. GuruFocus rates XMAD:NTH with a GF Score™ of 81/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,994 Consumer Packaged Goods companies, Naturhouse Health ranks better than 97.54% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Naturhouse Health's annualizedNet Income for the quarter that ended in Dec. 2025 was €7.81 Mil. Naturhouse Health's average total tangible assets for the quarter that ended in Dec. 2025 was €38.21 Mil. Therefore, Naturhouse Health's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 20.44%.
The historical rank and industry rank for Naturhouse Health's Return-on-Tangible-Asset or its related term are showing as below:
XMAD:NTH'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 21.29 Med: 28.28 Max: 55.89
Current: 25.53
During the past 13 years, Naturhouse Health's highest Return-on-Tangible-Asset was 55.89%. The lowest was 21.29%. And the median was 28.28%.
XMAD:NTH's Return-on-Tangible-Asset is ranked better than 97.54% of 1994
companies
in the Consumer Packaged Goods industry
Industry Median: 3.39
vs XMAD:NTH: 25.53
Naturhouse Health (XMAD:NTH) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Naturhouse Health Return-on-Tangible-Asset Related Terms
Naturhouse Health Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Naturhouse Health's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:NTH vs KHC, GIS, HRL: Return-on-Tangible-Asset Comparison
For the Packaged Foods subindustry, Naturhouse Health's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturhouse Health Return-on-Tangible-Asset vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Naturhouse Health's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 20.44% mean?
Naturhouse Health (XMAD:NTH) has a Return-on-Tangible-Asset of 20.44% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Naturhouse Health and its competitors. This is 28% below median its historical median of 28.28. Over the past decade, Naturhouse Health's Return-on-Tangible-Asset has ranged from 21.29 to 55.89. According to the industry distribution chart, Naturhouse Health ranks #49 out of 1994 companies in the Consumer Packaged Goods industry, placing it in the top 2.5%.
Is Naturhouse Health's Return-on-Tangible-Asset too high?
Naturhouse Health's current Return-on-Tangible-Asset of 20.44% is 28% below median its 10-year median of 28.28. Over the past 10 years, this metric has ranged from a low of 21.29 to a high of 55.89. The Consumer Packaged Goods industry median Return-on-Tangible-Asset is 3.39. Naturhouse Health's value of 20.44% is 502.9% above this industry median. Based on the distribution chart, Naturhouse Health ranks #49 out of 1994 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Naturhouse Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's Return-on-Tangible-Asset compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Naturhouse Health ranks #49 out of 1994 companies for Return-on-Tangible-Asset. This places Naturhouse Health in the top 3% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 3.39. Naturhouse Health's value of 20.44% is 502.9% above this benchmark. Historically, Naturhouse Health's own Return-on-Tangible-Asset has ranged from 21.29 to 55.89 over the past decade. While the company's 10-year median is 28.28 vs. the industry median of 3.39, Naturhouse Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Consumer Packaged Goods company?
The median Return-on-Tangible-Asset among Consumer Packaged Goods companies is 3.39, based on 1,994 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturhouse Health's current Return-on-Tangible-Asset of 20.44% is 502.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Naturhouse Health and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Asset is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturhouse Health's current Return-on-Tangible-Asset is 20.44%, which is 28% below median its own 10-year median of 28.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.52 — trading 55.6% above its estimated fair value. The current Return-on-Tangible-Asset is 20.44%, which is 28% below median its 10-year median of 28.28 and 502.9% above the Consumer Packaged Goods industry median of 3.39. Naturhouse Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current Return-on-Tangible-Asset is 20.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?
Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued.
The current stock price of €2.52 is trading 55.6% above its estimated GF Value™ of €1.62.
GuruFocus considers Naturhouse Health to be Significantly Overvalued.
Key valuation signals for XMAD:NTH:
Return-on-Tangible-Asset: 20.44% (28% below median its 10-year median of 28.28)
GF Value™: €1.62 vs. price of €2.52 (55.6% above fair value)
Industry Position: 502.9% above the Consumer Packaged Goods median (#49 of 1994)
No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
81GF Score
Get the complete analysis for XMAD:NTH
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:NTH has been successfully added to your 
